R R Soekhlal1, L T Burgers, W K Redekop, S S Tan. 1. Erasmus Universiteit Rotterdam, institute for Medical Technology Assessment, PO Box 1738, 3000 DR, Rotterdam, the Netherlands.
Abstract
BACKGROUND: This study aimed to calculate the treatment costs of acute myocardial infarction (AMI) in the Netherlands for 2012. Also, the degree of association between treatment costs of AMI and some patient and hospital characteristics was examined. METHODS: For this retrospective cost analysis, patients were drawn from the database of the Diagnosis Treatment Combination (Diagnose Behandeling Combinatie, DBC) casemix system, which contains data on the resource use of all hospitalisations in the Netherlands. All costs were based on Euro 2012 cost data. RESULTS: The analysis was based on data of 25,657 patients. Mean treatment costs were estimated at <euro> 5021, with significant cost increases for patients with percutaneous coronary intervention (PCI) treatment. ST-segment elevation myocardial infarction (STEMI) patients receiving thrombolysis incurred the lowest (<euro> 4286), while non-STEMI patients receiving PCI the highest costs (<euro> 6060). Length of stay and hospital type were strong predictors of treatment costs. CONCLUSIONS: This study is the most extensive cost assessment of the treatment costs of AMI in the Netherlands thus far. Our results may be used as input for health-economic models and economic evaluations to support the decision making of registration, reimbursement and pricing of interventions in healthcare.
BACKGROUND: This study aimed to calculate the treatment costs of acute myocardial infarction (AMI) in the Netherlands for 2012. Also, the degree of association between treatment costs of AMI and some patient and hospital characteristics was examined. METHODS: For this retrospective cost analysis, patients were drawn from the database of the Diagnosis Treatment Combination (Diagnose Behandeling Combinatie, DBC) casemix system, which contains data on the resource use of all hospitalisations in the Netherlands. All costs were based on Euro 2012 cost data. RESULTS: The analysis was based on data of 25,657 patients. Mean treatment costs were estimated at <euro> 5021, with significant cost increases for patients with percutaneous coronary intervention (PCI) treatment. ST-segment elevation myocardial infarction (STEMI) patients receiving thrombolysis incurred the lowest (<euro> 4286), while non-STEMI patients receiving PCI the highest costs (<euro> 6060). Length of stay and hospital type were strong predictors of treatment costs. CONCLUSIONS: This study is the most extensive cost assessment of the treatment costs of AMI in the Netherlands thus far. Our results may be used as input for health-economic models and economic evaluations to support the decision making of registration, reimbursement and pricing of interventions in healthcare.
Authors: Christian W Hamm; Jean-Pierre Bassand; Stefan Agewall; Jeroen Bax; Eric Boersma; Hector Bueno; Pio Caso; Dariusz Dudek; Stephan Gielen; Kurt Huber; Magnus Ohman; Mark C Petrie; Frank Sonntag; Miguel Sousa Uva; Robert F Storey; William Wijns; Doron Zahger Journal: Eur Heart J Date: 2011-08-26 Impact factor: 29.983
Authors: J Z Atary; M de Visser; R van den Dijk; J Bosch; S S Liem; M L Antoni; M Bootsma; E P Viergever; C J Kirchhof; I Padmos; M I Sedney; H J van Exel; H F Verwey; D E Atsma; E E van der Wal; J W Jukema; M J Schalij Journal: Neth Heart J Date: 2010-09 Impact factor: 2.380
Authors: Taulant Muka; David Imo; Loes Jaspers; Veronica Colpani; Layal Chaker; Sven J van der Lee; Shanthi Mendis; Rajiv Chowdhury; Wichor M Bramer; Abby Falla; Raha Pazoki; Oscar H Franco Journal: Eur J Epidemiol Date: 2015-01-18 Impact factor: 8.082
Authors: Bert Everaert; Cordula Felix; Jacques Koolen; Peter den Heijer; Jose Henriques; Joanna Wykrzykowska; Rene van der Schaaf; Bart de Smet; Sjoerd Hofma; Roberto Diletti; Nicolas Van Mieghem; Evelyn Regar; Peter Smits; Robert-Jan M van Geuns Journal: Neth Heart J Date: 2015-03 Impact factor: 2.380
Authors: Qian Li; Zhenqiu Lin; Frederick A Masoudi; Jing Li; Xi Li; Sonia Hernández-Díaz; Sudhakar V Nuti; Lingling Li; Qing Wang; John A Spertus; Frank B Hu; Harlan M Krumholz; Lixin Jiang Journal: BMC Cardiovasc Disord Date: 2015-01-20 Impact factor: 2.298
Authors: Manon C Stam-Slob; Yolanda van der Graaf; Jacoba P Greving; Jannick A N Dorresteijn; Frank L J Visseren Journal: J Am Heart Assoc Date: 2017-02-18 Impact factor: 5.501
Authors: Jelena Stevanović; Marjolein Pompen; Hoa H Le; Mark H Rozenbaum; Robert G Tieleman; Maarten J Postma Journal: PLoS One Date: 2014-08-05 Impact factor: 3.240